Dextromethorphan/quinidine: a novel dextromethorphan product for the treatment of emotional lability.
about
PRISM: a novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditionsReview of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA(®)) for Pseudobulbar Affect.Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affectEnhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial.
P2860
Dextromethorphan/quinidine: a novel dextromethorphan product for the treatment of emotional lability.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Dextromethorphan/quinidine: a ...... eatment of emotional lability.
@ast
Dextromethorphan/quinidine: a ...... eatment of emotional lability.
@en
type
label
Dextromethorphan/quinidine: a ...... eatment of emotional lability.
@ast
Dextromethorphan/quinidine: a ...... eatment of emotional lability.
@en
prefLabel
Dextromethorphan/quinidine: a ...... eatment of emotional lability.
@ast
Dextromethorphan/quinidine: a ...... eatment of emotional lability.
@en
P2860
P1476
Dextromethorphan/quinidine: a ...... eatment of emotional lability.
@en
P2093
Richard Alan Smith
P2860
P304
P356
10.1517/14656566.7.18.2581
P407
P577
2006-12-01T00:00:00Z